2025 Perinatal Substance Use

Benzodiazepine Use in the Perinatal Period

Many pregnant people take benzodiazepines. This presentation focuses on the impact of benzodiazepines throughout the perinatal period.

Register to unlock the course, then click ‘Continue.’ Course materials are available at the bottom of this page.
Write your awesome label here.
Patrick Jones - Course author
Meet the instructor

Ann Ebert, PharmD

Ann Ebert is the Perinatal Clinical Pharmacy Specialist at UnityPoint Health–Meriter Hospital in Madison, Wisconsin, and a Clinical Assistant Professor of Pharmacy at the University of Wisconsin. She earned her Pharm.D. from the University of Minnesota and completed a pediatric clinical pharmacy residency before joining Meriter Hospital.

 

The speaker has no relevant financial relationships with ineligible companies.*

Learning Outcomes

At the conclusion of this activity, participants will be able to:
  • Describe the pharmacology of benzodiazepines.
  • Review the clinical use of benzodiazepines.
  • Evaluate the safety of benzodiazepines in the pregnant person.
  • Discuss alternatives to benzodiazepines.


Accreditation Statement

Continuing Medical Education

The Wisconsin Association for Perinatal Care is accredited by the Wisconsin Medical Society to provide continuing medical education for physicians.

The Wisconsin Association for Perinatal Care (WAPC) designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Course Content

Planning Committee

No one in control of content has any relevant financial relationships with ineligible companies.*

Course Information

This webinar was recorded on February 13, 2025.

The expiration date for this course is October 6, 2028.

*Ineligible companies are those whose primary business is producing, marketing, selling, reselling, or distributing health care products used by or on patients.